Rationale: Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS) can make a patient more likely to become seriously ill if they get COVID-19. Bronchiectasis, defined as bronchial dilatations has been described in patients who have suffered COVID-19 pneumonia in the acute phase of the disease. Ischemic heart disease represents a serious association. Diabetic ketoacidosis has been detected in patients with COVID-19. Wavy triple an electrocardiographic sign (Yasser’s sign) is a new specific diagnostic sign seen in the cases of hy-pocalcemia and can be used as a therapeutic guide in cases of hypocalcemia. Pneumocystis pneumonia (PCP) is a serious infection caused by the fungus Pneumocystis jirovecii. Most patients with HIV/AIDS who get PCP have immune insufficiency. About 30-40% of people who get PCP have HIV/AIDS.
Patient concerns: A 53-year-old, worker, married male, Egyptian patient was presented to the emergency depart-ment with fever, tachycardia, tachypnea, diabetic ketoacidosis, and chest pain. He was previously diagnosed as an HIV/AIDS patient.
Diagnosis: Pneumonia with bronchiectasis, diabetic ketoacidosis, and electrocardiographic Wavy triple or Yass-er’s sign, in HIV patient at initial COVID pandemic with possible PCP.
Interventions: Chest CT, electrocardiography, and oxygenation.
Outcomes: Good response and outcomes in the presence of numerous remarkable serious risk factors were the results.
Lessons: The association of COVID pneumonia with diabetic ketoacidosis in a patient with immunodeficiency disease such as HIV/AIDS is highly interesting in the deterioration of the case. Diabetes, male sex, COVID-19 pneumonia, ischemic heart disease, bronchiectasis, wavy triple an electrocardiographic sign (Yasser’s sign), the HIV/AIDS disease, and possible pneumocystis pneumonia are constellation serious risk factors.
Keywords: Emerge of COVID pandemic, Bronchiectasis, HIV/AIDS, Wavy triple sign (Yasser’s sign), Ketoacidosis, Hypocalcemia, Pneumocystis pneumonia (PCP)